期刊
CLINICAL IMMUNOLOGY
卷 118, 期 2-3, 页码 300-306出版社
ACADEMIC PRESS INC ELSEVIER SCIENCE
DOI: 10.1016/j.clim.2005.09.019
关键词
plasmacytoid dendritic cells; glucocorticoid; interferon-alpha; Toll-like receptor; apoptosis; differentiation
类别
资金
- NIAID NIH HHS [AI 41011, AI 60994] Funding Source: Medline
- NIDDK NIH HHS [DK 49745] Funding Source: Medline
Plasmacytoid dendritic cells (pDC) are an important source of type-1 interferon (IFN) following microbial infection and also play key roles in the induction of innate and adaptive immune responses. Here, we show that the glucocorticoid (GC) dexamethasone (Dex) strikingly reduces pDC (and myeloid DC) numbers in secondary lymphoid tissue and liver of normal and hematopoietic growth factor-mobilized mice and suppresses pDC differentiation from bone marrow precursors in vitro. Moreover, the apoptotic death of pDC in vitro was enhanced by exposure to Dex. Notably, however, Toll-like receptor 9 expression and virally induced IFN alpha production by residual pDC from Dex-treated animals were unaffected. Thus, whereas marked reduction in absolute numbers of pDC by GC may predispose to viral infection, often associated with GC-mediated immuno suppression, reductions in pDC and IFN alpha production may contribute to the beneficial effects on GC observed in systemic autoimmune disease, in which that both pDC and IFN alpha have been implicated. alpha 2005 Elsevier Inc. All rights reserved.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据